Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 2 1

Status

Enrolling by invitation 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 1044Neoplasms 874Prostatic Neoplasms 509Lung Neoplasms 424Colorectal Neoplasms 358Motor Activity 222Head and Neck Neoplasms 195Uterine Cervical Neoplasms 190Carcinoma, Non-Small-Cell Lung 181Brain Neoplasms 175Pancreatic Neoplasms 160Ovarian Neoplasms 140Carcinoma, Hepatocellular 139Colonic Neoplasms 136Anxiety Disorders 125Rectal Neoplasms 117Hematologic Neoplasms 115Multiple Myeloma 106Stomach Neoplasms 102Neoplasm Metastasis 101Melanoma 94Precursor Cell Lymphoblastic Leukemia-Lymphoma 93Depression 93Urinary Bladder Neoplasms 89Pain 88Endometrial Neoplasms 87Glioblastoma 85Disease 83Lymphoma 81Sarcoma 79

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × DiGeorge Syndrome × 1 year × Clear all
NCT03836300 2025-07-31

Parent and Infant Inter(X)Action Intervention (PIXI)

RTI International

Phase NA Enrolling by invitation
120 enrolled

Telomeric 22q13 Monosomy Syndrome, Developmental Disabilities, DiGeorge Syndrome, Down Syndrome, Fragile X Syndrome, Klinefelter Syndrome, Prader-Willi Syndrome, Tuberous Sclerosis, Turner Syndrome, Rett Syndrome, Angelman Syndrome, Williams Syndrome, Muscular Dystrophy, Duchenne, Smith-Magenis Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡